Design of Tissue-specific Regulatory Cassettes for High-level rAAV-mediated Expression in Skeletal and Cardiac Muscle
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Systemic delivery of recombinant adeno-associated virus (rAAV) 6 vectors mediates efficient transduction of the entire striated musculature, making this an attractive strategy for muscle gene therapy. However, owing to widespread transduction of non-muscle tissues, optimization of this method would benefit from the use of muscle-specific promoters. Most such promoters either lack high-level expression in certain muscle types or are too large for inclusion in rAAV vectors encoding microdystrophin. Here, we describe novel regulatory cassettes based on enhancer/promoter regions of murine muscle creatine kinase (CK) and alpha-myosin heavy-chain genes. The strongest cassette, MHCK7 (770 bp), directs high-level expression comparable to cytomegalovirus and Rous sarcoma virus promoters in fast and slow skeletal and cardiac muscle, and low expression in the liver, lung, and spleen following systemic rAAV6 delivery in mice. Compared with CK6, our previous best cassette, MHCK7 activity is approximately 400-, approximately 50-, and approximately 10-fold higher in cardiac, diaphragm, and soleus muscles, respectively. MHCK7 also directs strong microdystrophin expression in mdx muscles. While further study of immune responses to MHCK7-regulated microdystrophin expression is needed, this cassette is not active in dendritic cell lines. MHCK7 is thus a highly improved regulatory cassette for experimental studies of rAAV-mediated transduction of striated muscle.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relative tissue-specific expression of two gRNAs for CRISPR/Cas gene editing in myotubes was achieved by linking a muscle-specific MHCK7 promoter (pol II) with gRNA-linked self-cleaving ribozyme sequences derived of Hepatitis delta virus (HDV) and a Hammerhead (HH) sequence [134-137].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [135]
Citations
Cites
Three myosin heavy chain isoforms in type 2 skeletal muscle fibres
Schiaffino, S., Gorza, L., Sartore, S., Saggin, L., Ausoni, S., Vianello, M., Gundersen, K., & LØmo, T. (1989) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf01739810 · Cited by 954
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
Self-citationKessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Inagaki, K., Fuess, S., Storm, T. A., Gibson, G. A., Mctiernan, C. F., Kay, M. A., & Nakai, H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.014 · Cited by 610
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J., & Xiao, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1073 · Cited by 608
Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
Bottinelli, R., Schiaffino, S., & Reggiani, C. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018617 · Cited by 486
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
Pacak, C. A., Mah, C. S., Thattaliyath, B. D., Conlon, T. J., Lewis, M. A., Cloutier, D. E., Zolotukhin, I., Tarantal, A. F., & Byrne, B. J. (2006) · Circulation Research · doi:10.1161/01.res.0000237661.18885.f6 · Cited by 406
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Gregorevic, P., Allen, J. M., Minami, E., Blankinship, M. J., Haraguchi, M., Meuse, L., Finn, E., Adams, M. E., Froehner, S. C., Murry, C. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1439 · Cited by 307
Self-citationEfficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
Blankinship, M. J., Gregorevic, P., Allen, J. M., Harper, S. Q., Harper, H., Halbert, C. L., Miller, D. A., & Chamberlain, J. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.016 · Cited by 251
Self-citationSynthetic muscle promoters: activities exceeding naturally occurring regulatory sequences
Li, X., Eastman, E. M., Schwartz, R. J., & Draghia-Akli, R. (1999) · Nature Biotechnology · doi:10.1038/6981 · Cited by 245
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J., Surosky, R., Lochrie, M., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0495 · Cited by 208
Self-citationJohnson, J. E., Wold, B. J., & Hauschka, S. D. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3393 · Cited by 207
Self-citationForced expression of dystrophin deletion constructs reveals structure-function correlations.
Rafael, J. A., Cox, G. A., Corrado, K., Jung, D., Campbell, K. P., & Chamberlain, J. S. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.1.93 · Cited by 184
Self-citationMULLER, O., LEUCHS, B., PLEGER, S., GRIMM, D., FRANZ, W., KATUS, H., & KLEINSCHMIDT, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.017 · Cited by 157
Cordier, L., Gao, G.-P., Hack, A. A., McNally, E. M., Wilson, J. M., Chirmule, N., & Sweeney, H. L. (2001) · Human Gene Therapy · doi:10.1089/104303401750061267 · Cited by 152
Black, B. L., Molkentin, J. D., & Olson, E. N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.69 · Cited by 145
Amacher, S. L., Buskin, J. N., & Hauschka, S. D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2753 · Cited by 140
Self-citationYuasa, K., Sakamoto, M., Miyagoe‐Suzuki, Y., Tanouchi, A., Yamamoto, H., Li, J., Chamberlain, J. S., Xiao, X., & Takeda, S. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301829 · Cited by 138
Self-citationYoshimura, M., Sakamoto, M., Ikemoto, M., Mochizuki, Y., Yuasa, K., Miyagoe-Suzuki, Y., & Takeda, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.025 · Cited by 116
Shield, M. A., Haugen, H. S., Clegg, C. H., & Hauschka, S. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5058 · Cited by 115
Self-citationSun, B., Zhang, H., Franco, L. M., Brown, T., Bird, A., Schneider, A., & Koeberl, D. D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.012 · Cited by 111
Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin
Scott, J. M., Li, S., Harper, S. Q., Welikson, R. E., Bourque, D. L., DelloRusso, C., Hauschka, S. D., & Chamberlain, J. S. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00078-0 · Cited by 106
Self-citationImmune Evasion by Muscle-Specific Gene Expression in Dystrophic Muscle
Hartigan-O'Connor, D., Kirk, C. J., Crawford, R., Mulé, J. J., & Chamberlain, J. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0496 · Cited by 101
Self-citationAnalysis of Muscle Creatine Kinase Regulatory Elements in Recombinant Adenoviral Vectors
Hauser, M. A., Robinson, A., Hartigan-O'Connor, D., Williams-Gregory, D., Buskin, J. N., Apone, S., Kirk, C. J., Hardy, S., Hauschka, S. D., & Chamberlain, J. S. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0089 · Cited by 99
Self-citationEmami, K. H., Jain, A., & Smale, S. T. (1997) · Genes & Development · doi:10.1101/gad.11.22.3007 · Cited by 94
Zhu, T., Zhou, L., Mori, S., Wang, Z., McTiernan, C. F., Qiao, C., Chen, C., Wang, D. W., Li, J., & Xiao, X. (2005) · Circulation · doi:10.1161/circulationaha.105.565598 · Cited by 94
B. Donoviel, D., A. Shield, M., N. Buskin, J., S. Haugen, H., H. Clegg, C., & D. Hauschka, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1649 · Cited by 92
Self-citationMolkentin, J. D. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0112 · Cited by 87
Hagstrom, J. N., Couto, L. B., Scallan, C., Burton, M., McCleland, M. L., Fields, P. A., Arruda, V. R., Herzog, R. W., & High, K. A. (2000) · Blood · doi:10.1182/blood.v95.8.2536 · Cited by 80
Allen, D. L., Harrison, B. C., Sartorius, C., Byrnes, W. C., & Leinwand, L. A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c637 · Cited by 75
Allen, J. M., Halbert, C. L., & Miller, A. D. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0010 · Cited by 73
Self-citationMah, C. S., Cresawn, K. O., Fraites, T. J., Pacak, C. A., Lewis, M. A., Zolotukhin, I., & Byrne, B. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302550 · Cited by 73
Chapter 5 Skeletal Muscle Cultures
Neville, C. M., Rosenthal, N. A., McGrew, M. J., Bogdanova, N., & Hauschka, S. D. (1997) · Methods in cell biology · doi:10.1016/s0091-679x(08)60375-1 · Cited by 72
Self-citationCharacterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene
Wade, D. P., Puckey, L., Knight, B. L., Acquati, F., Mihalich, A., & Taramelli, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30387 · Cited by 60
Liu, Y.-L., Mingozzi, F., Rodriguéz-Colôn, S. M., Joseph, S., Dobrzynski, E., Suzuki, T., High, K. A., & Herzog, R. W. (2004) · Human Gene Therapy · doi:10.1089/1043034041648453 · Cited by 54
Dunant, P., Larochelle, N., Thirion, C., Stucka, R., Ursu, D., Petrof, B. J., Wolf, E., & Lochmüller, H. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00129-1 · Cited by 44
Effect of muscle origin and phenotype on satellite cell muscle-specific gene expression
LaFramboise, W. A. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00245-1 · Cited by 38
Differing patterns of capillary distribution in fish and mammalian skeletal muscle
Egginton, S., Turek, Z., & Hoofd, L. J. C. (1988) · Respiration Physiology · doi:10.1016/0034-5687(88)90045-x · Cited by 35
Gonin, P., Arandel, L., Van Wittenberghe, L., Marais, T., Perez, N., & Danos, O. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.716 · Cited by 29
Jiang, Z., Schiedner, G., Gilchrist, S., Kochanek, S., & Clemens, P. R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302315 · Cited by 25
Nguyen, Q.-G. V., Buskin, J. N., Himeda, C. L., Shield, M. A., & Hauschka, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308194200 · Cited by 25
Self-citationMyosin regulatory elements as vectors for gene transfer by intramuscular injection
Skarli, M., Kiri, A., Vrbovà, G., Lee, C., & Goldspink, G. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300618 · Cited by 21
Nguyen, Q.-G. V., Buskin, J. N., Himeda, C. L., Suver, C., & Hauschka, S. D. (2003) · Transgenic Research · doi:10.1023/a:1023369225799 · Cited by 20
Self-citation
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Self-citationTabebordbar, M., Lagerborg, K. A., Stanton, A., King, E. M., Ye, S., Tellez, L., Krunnfusz, A., Tavakoli, S., Widrick, J. J., Messemer, K. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.028 · Cited by 506
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Hong, E.-G., Ko, H. J., Cho, Y.-R., Kim, H.-J., Ma, Z., Yu, T. Y., Friedline, R. H., Kurt-Jones, E., Finberg, R., Fischer, M. A., et al. (2009) · Diabetes · doi:10.2337/db08-1261 · Cited by 411
Self-citationMendell, J. R., Sahenk, Z., Lehman, K., Nease, C., Lowes, L. P., Miller, N. F., Iammarino, M. A., Alfano, L. N., Nicholl, A., Al-Zaidy, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1484 · Cited by 405
Metadata
- Authors
- Salva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., Chamberlain, J. S., & Hauschka, S. D.
- Affiliations
- University of Washington (US)
- Corresponding author
- Hauschka, Stephen D
- ORCID
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 15
- Issue
- 2
- Pages
- 320-329
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2065979540
- Cited by
- 232
- References
- 46
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 22 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 12 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 3536 d)
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R24HL064387)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR018860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007183, U54HD047175)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- muscle-specific promoter, muscle creatine kinase, alpha-myosin heavy chain, microdystrophin, mdx mice, skeletal muscle, myocardium, tissue-specific gene expression
- MeSH terms
- Dependovirus, Animals, Cell Line, Cells, Cultured, Cloning, Molecular, Creatine Kinase, Fluorescent Antibody Technique, Gene Expression Regulation, Genetic Vectors, Humans, Male, Mice, Inbred C57BL, Myocardium, Promoter Regions, Genetic, Transfection, Muscle, Skeletal, Ventricular Myosins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.